Abstract
Flu risk and burden much higher than assumed: Each year, influenza affects hundreds of millions of people. In order to limit the burden, influenza should remain at the top of the public health priority list. Butinfluenza has attracted less attention recently and priorities and perceptions now differ around the globe, varying with the different cultural and economical contexts. For example, priorities in less-developedcountries differ from those in developed countries. For this reason, every approach for raising awarenessneeds to be tailor-made, capable of responding to every specific stakeholder context. New evidenceunderpins the effectiveness of flu vaccination in reducing coronary heart disease and death, providingvaccine advocacy with a powerful argument.
Original language | English (US) |
---|---|
Pages (from-to) | 7022-7025 |
Number of pages | 4 |
Journal | Vaccine |
Volume | 33 |
Issue number | 49 |
DOIs | |
State | Published - Dec 8 2015 |
Keywords
- Influenza
ASJC Scopus subject areas
- Molecular Medicine
- General Immunology and Microbiology
- General Veterinary
- Public Health, Environmental and Occupational Health
- Infectious Diseases